Oxford Drug Design has contributed to an article in the March edition of Chemistry World. The article, entitled “Countdown to the last antibiotic” written by science writer and lecturer Clare Sansom, focuses on where the next generation of antibiotics might come from and describes many of the barriers faced by those working in the field. The major role of small biotech companies, following the withdrawal of many big pharma companies from antibiotics R&D, is a feature of the article, illustrated by the innovative work at Oxford Drug Design to identify new classes of antibiotics with novel mechanisms of action.